Cargando…
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins
Glioblastoma (GBM) treatment includes maximal safe resection of the core and MRI contrast-enhancing (CE) tumor. Complete resection of the infiltrative non-contrast-enhancing (NCE) tumor rim is rarely achieved. We established a safe, semi-automated workflow for spatially-registered sampling of MRI-de...
Autores principales: | Grabowski, Matthew M., Watson, Dionysios C., Chung, Kunho, Lee, Juyeun, Bayik, Defne, Lauko, Adam, Alban, Tyler, Melenhorst, Jan Joseph, Chan, Timothy, Lathia, Justin D., Ahluwalia, Manmeet S., Mohammadi, Alireza M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029063/ https://www.ncbi.nlm.nih.gov/pubmed/36945620 http://dx.doi.org/10.1101/2023.03.09.23285970 |
Ejemplares similares
-
OTEH-2. High-dimensional analysis of spatial immune cell heterogeneity in glioblastoma reveals differences between contrast-enhancing and non-contrast-enhancing tumor rims
por: Watson, Dionysios C, et al.
Publicado: (2021) -
IL-11 drives postsurgical hepatocellular carcinoma recurrence
por: Lauko, Adam, et al.
Publicado: (2019) -
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
por: Bayik, Defne, et al.
Publicado: (2022) -
Release the ballast: Glioblastoma rises above radiation therapy by exporting miR-603 in extracellular vesicles to become treatment-resistant
por: Bayik, Defne, et al.
Publicado: (2020) -
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
por: Lee, Juyeun, et al.
Publicado: (2023)